User:georgiamozz596802

Emibetuzumab, previously known as LY2875358, represents a novel medicinal approach in oncology, specifically targeting the HGF Receptor tyrosine protein. This engineered protein functions by

https://www.targetmol.com/compound/emibetuzumab